stockrow
Friday 6 November 2026
Export COR’s income statement to Excel — free account
Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.
- Revenue
- +5.52%
- EPS
- +258.4%
- Free cash flow
- −7.81%
- Total debt
- +47.1%
Quarter to September 2026, against a year earlier
335.01
4.67
−1.37%
Follow COR
Alert me
Cencora, Inc. (COR) Revenue
Cencora, Inc.'s revenue for fiscal 2026 was $337.4B, unchanged from fiscal 2025. Over the past ten years it has ranged from $136.0B (fiscal 2015) to $337.4B (fiscal 2026) — the current reading is the highest in ten years. Revenue has risen for 11 consecutive fiscal years. Cencora, Inc. ranks 2nd of 11 Medical Distribution companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2026 | $337.4B | 5.00% |
| FY2025 | $321.3B | 9.31% |
| FY2024 | $294.0B | 12.12% |
| FY2023 | $262.2B | 9.89% |
| FY2022 | $238.6B | 11.50% |
| FY2021 | $214.0B | 12.69% |
| FY2020 | $189.9B | 5.74% |
| FY2019 | $179.6B | 6.94% |
| FY2018 | $167.9B | 9.66% |
| FY2017 | $153.1B | 4.29% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $88.4B | 4.25% |
| Jun 2026 | $84.8B | 8.17% |
| Mar 2026 | $78.4B | (8.82%) |
| Dec 2025 | $85.9B | 2.63% |
| 43 more quarters | Free account |
Against its own ten years
Low $136.0B
High $337.4B
Ten-year median
$201.9B
Current reading's percentile
100
Revenue against peers
| Company | Revenue |
|---|---|
| MCK McKesson Corporation compare | $418.8B |
| COR Cencora, Inc. | $337.4B |
| CAH Cardinal Health, Inc. compare | $257.8B |
| HSIC Henry Schein, Inc. compare | $13.7B |
| ACH Accendra Health, Inc. compare | $2.6B |
| YI 111, Inc. Sponsored ADR compare | $1.7B |
| FOCL FocalTherics compare | $77.8M |
| COSM Cosmos Health Inc. compare | $73.7M |
| AHG Akso Health Group Sponsored ADR compare | $20.1M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on COR
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement